Insider · CIK 0001691265

Conner Edward R.

Reports to the SEC for 5 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001691265

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-15	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+132K sh	—	—	132,000
2025-01-15	Third Harmonic Bio, Inc.Restricted Stock UnitA Award	Chief Medical Officer	AAward	+16.5K sh	—	—	16,500
2024-11-08	Third Harmonic Bio, Inc.S Sale	Chief Medical Officer	SSale	−2,117 sh	$15.00	−$31.8K	0
2024-11-08	Third Harmonic Bio, Inc.Employee Option Grant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,117 sh	—	—	368,918
2024-11-08	Third Harmonic Bio, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,117 sh	$4.20	+$8,891.4	2,117
2024-10-28	Third Harmonic Bio, Inc.Employee Option Grant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,673 sh	—	—	371,035
2024-10-28	Third Harmonic Bio, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,673 sh	$4.20	+$11.2K	2,673
2024-10-28	Third Harmonic Bio, Inc.S Sale	Chief Medical Officer	SSale	−2,673 sh	$15.00	−$40.1K	0
2024-09-19	Third Harmonic Bio, Inc.S Sale	Chief Medical Officer	SSale	−4,790 sh	$15.00	−$71.9K	0
2024-09-19	Third Harmonic Bio, Inc.Employee Option Grant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,790 sh	—	—	373,708
2024-09-19	Third Harmonic Bio, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,790 sh	$4.20	+$20.1K	4,790
2024-01-05	Third Harmonic Bio, Inc.Employee Option Grant (right to buy)A Award	Chief Medical Officer	AAward	+133K sh	—	—	133,000
2023-12-05	Third Harmonic Bio, Inc.S Sale	Chief Medical Officer	SSale	−4,790 sh	$10.03	−$48.1K	0
2023-12-05	Third Harmonic Bio, Inc.Employee Option Grant (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,790 sh	—	—	378,498
2023-12-05	Third Harmonic Bio, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,790 sh	$4.20	+$20.1K	4,790
2023-03-06	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+137K sh	—	—	137,000
2023-03-06	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−383K sh	—	—	0
2023-03-06	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+383K sh	—	—	383,288
2023-03-06	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−95K sh	—	—	0
2023-03-06	Third Harmonic Bio, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+95K sh	—	—	95,000
2022-10-25	Third Harmonic Bio, Inc.Employee Option Grant (right to buy)A Award	Chief Medical Officer	AAward	+95K sh	—	—	95,000
2022-06-02	ELVNEnliven Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2021-06-29	ELVNEnliven Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+7,728 sh	—	—	7,728
2020-04-22	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,457
2020-01-15	Audentes Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Medical Officer	DDisposition to Issuer	−90K sh	—	—	0
2020-01-15	Audentes Therapeutics, Inc.U Disposition from Tender	SVP, Chief Medical Officer	UDisposition from Tender	−24.6K sh	$60.00	−$1.48M	0
2019-12-12	Audentes Therapeutics, Inc.F Tax Payment	SVP, Chief Medical Officer	FTax Payment	−5,416 sh	$59.37	−$322K	24,584
2019-07-15	Audentes Therapeutics, Inc.A Award	SVP, Chief Medical Officer	AAward	+30K sh	—	—	30,000
2019-07-15	Audentes Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, Chief Medical Officer	AAward	+90K sh	—	—	90,000
2019-01-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Sr. VP & Chief Medical Officer	FTax Payment	−834 sh	$11.10	−$9,257.4	11,291
2019-01-07	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$3.20	+$16K	17,125
2019-01-07	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	130,000
2019-01-07	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,000 sh	$12.33	−$61.6K	12,125
2018-12-06	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	135,000
2018-12-06	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$3.20	+$16K	17,125
2018-12-06	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,000 sh	$11.49	−$57.4K	12,125
2018-11-06	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,000 sh	$13.73	−$68.7K	12,125
2018-11-06	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	140,000
2018-11-06	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$3.20	+$16K	17,125
2018-10-08	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	145,000
2018-10-08	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$3.20	+$16K	15,125
2018-10-08	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,000 sh	$14.55	−$72.8K	10,125
2018-09-06	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$3.20	+$16K	15,125
2018-09-06	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	150,000
2018-09-06	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,000 sh	$14.17	−$70.8K	10,125
2018-08-06	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,000 sh	$13.45	−$67.3K	10,125
2018-08-06	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$3.20	+$16K	15,125
2018-08-06	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	155,000
2018-07-06	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$3.20	+$16K	15,125
2018-07-06	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,000 sh	$15.79	−$79K	10,125

Recent filings

Accepted (ET)
Jan 174
Conner Edward R.0001415889-25-001723
SEC(opens sec.gov)
Nov 124
Conner Edward R.0001415889-24-026626
SEC(opens sec.gov)
Oct 304
Conner Edward R.0001415889-24-025750
SEC(opens sec.gov)
Sep 204
Conner Edward R.0001415889-24-023788
SEC(opens sec.gov)
Jan 94
Conner Edward R.0001209191-24-001233
SEC(opens sec.gov)
Dec 74
Conner Edward R.0001209191-23-057712
SEC(opens sec.gov)
Mar 84
Conner Edward R.0001209191-23-017233
SEC(opens sec.gov)

Companies

Address

C/O THIRD HARMONIC BIO, INC. 1700 MONTGOMERY STREET, SUITE 210

SAN FRANCISCO, CA, 94111